3',4'-Methylenedioxy-α-pyrrolidinopropiophenone explained

3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills. It shares a similar chemical structure with α-PPP and MDPV, and has been shown to have reinforcing effects in rats.^[1]

Metabolism

MDPPP appears to have a similar metabolic fate as MDPV.

Legal Status

MDPPP is a controlled substance in China.^[2]

See also

• α-Pyrrolidinopropiophenone (α-PPP)
• 4'-Methyl-α-pyrrolidinopropiophenone (MPPP)
• 4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP)
• 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP)
• Dimethylone

Notes and References

1. Gannon BM, Galindo KI, Mesmin MP, Sulima A, Rice KC, Collins GT . Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats . Neuropharmacology . 134 . Pt A . 28–35 . May 2018 . 28811192 . 5809320 . 10.1016/j.neuropharm.2017.08.018 .
2. Web site: 关于印发《非药用类麻醉药品和精神药品列管办法》的通知 . China Food and Drug Administration . 27 September 2015 . Chinese . 1 October 2015 . https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html . 1 October 2015 . dead .